首站-论文投稿智能助手
典型文献
Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells
文献摘要:
The tumor suppressor p53 is usually inactivated by somatic mutations in malignant neoplasms,and its reactivation represents an attractive therapeutic strategy for cancers.Here,we reported that a new quinolone compound RYL-687 significantly inhibited non-small cell lung cancer(NSCLC)cells which express wild type(wt)p53,in contract to its much weaker cytotoxicity on cells with mutant p53.RYL-687 upregulated p53 in cells with wt but not mutant p53,and ectopic expression of wt p53 significantly enhanced the anti-NSCLC activity of this compound.RYL-687 induced production of reactive oxygen species(ROS)and upregulation of Nrf2,leading to an elevation of the NAD(P)H:quinoneoxidoreductase-1(NQO1)that can protect p53 by inhibiting its degradation by 20S proteasome.RYL-687 bound NQO1,facilitating the physical interaction between NQO1 and p53.NQO1 was required for RYL-687-induced p53 accumulation,because silencing of NQO1 by specific siRNA or an NQO1 inhibitor uridine,drastically suppressed RYL-687-induced p53 upregulation.Moreover,a RYL-687-related prodrug significantly inhibited tumor growth in NOD-SCID mice inoculated with NSCLC cells and in a wt p53-NSCLC patient-derived xenograft mouse model.These data indicate that targeting NQO1 is a rational strategy to reactivate p53,and RYL-687 as a p53 stabilizer bears therapeutic potentials in NSCLCs with wt p53.
文献关键词:
作者姓名:
Hong Yu;Hong-ying Gao;Hua Guo;Gui-zhen Wang;Yi-qing Yang;Qian Hu;Li-jun Liang;Qun Zhao;Da-wei Xie;Yu Rao;Guang-biao Zhou
作者机构:
School of Chinese Materia Medica,Beijing University of Chinese Medicine,Beijing 100029,China;State Key Laboratory of Molecular Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;MOE Key Laboratory of Protein Sciences,School of Pharmaceutical Sciences,MOE Key Laboratory of Bioorganic Phosphorus Chemistry&Chemical Biology,and School of Medicine and Collaborative Innovation Center of Biotherapy,Tsinghua University,Beijing 100084,China;Hubei University of Medicine,Shiyan 442000,China
引用格式:
[1]Hong Yu;Hong-ying Gao;Hua Guo;Gui-zhen Wang;Yi-qing Yang;Qian Hu;Li-jun Liang;Qun Zhao;Da-wei Xie;Yu Rao;Guang-biao Zhou-.Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells)[J].中国药理学报(英文版),2022(03):692-702
A类:
RYL,quinoneoxidoreductase,NSCLCs
B类:
Upregulation,wild,type,p53,by,small,molecule,induced,elevation,NQO1,lung,cells,tumor,suppressor,usually,inactivated,somatic,mutations,malignant,neoplasms,its,reactivation,represents,attractive,therapeutic,strategy,cancers,Here,reported,that,new,quinolone,compound,significantly,inhibited,which,contract,much,weaker,cytotoxicity,mutant,upregulated,but,not,ectopic,expression,enhanced,anti,activity,this,production,reactive,oxygen,species,ROS,upregulation,Nrf2,leading,NAD,protect,inhibiting,degradation,20S,proteasome,bound,facilitating,physical,interaction,between,was,required,accumulation,because,silencing,specific,siRNA,inhibitor,uridine,drastically,suppressed,Moreover,related,prodrug,growth,NOD,SCID,mice,inoculated,patient,derived,xenograft,mouse,model,These,data,indicate,targeting,rational,reactivate,stabilizer,bears,potentials
AB值:
0.515339
相似文献
N6?methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
Xian Lin;Feng Wang;Jian Chen;Jing Liu;Yi?Bin Lin;Li Li;Chuan?Ben Chen;Qin Xu-Departments of Gynecology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Department of Radiation Oncology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Shenzhen Key Laboratory of Immunity and Inflammatory Diseases,Peking University Shenzhen Hospital,Shenzhen Peking University?the Hong Kong University of Science and Technology Medical Center,Shenzhen 518036,Guangdong,China;Outpatient Department,Fujian Hospital of People's Armed Police,Fujian Medical University,Fuzhou 350014,China
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity
Zhang Weiwei;Yan Wenji;Qian Niansong;Han Quanli;Zhang Weitao;Dai Guanghai-Chinese People’s Liberation Army Medical School, Beijing 100853, China;Department of the Third Health Care, The Second Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The First Medical Center, Chinese People’s Liberation Army General Hospital, Beijing 100853, China;Department of Oncology, The Hainan Medical Center, Chinese People’s Liberation Army General Hospital, Sanya 572022, China;Cancer Center, Beijing Tongren Hospital Affiliated to Capital Medical University, Economic and Technological Development Zone, Beijing 100176, China
In-silico and in-vitro evaluation of docetaxel and berberine as potential p53 modulating apoptotic inducers in oral squamous cell carcinoma
Smrutipragnya Samal;Rajesh Kumar Meher;Debasmita Dubey;Showkat Ahmad Mir;Binata Nayak;Mahesh Chandra Sahu;Pradeep Kumar Naik;Goutam Rath;Santosh Kumar Swain-Department of Otorhinolaryngology and Head and Neck Surgery,IMS and SUM Hospital,Siksha'O'Anusandhan Deemed to be University,K8,Kalinga Nagar,Bhubaneswar-751003,Odisha,India;Centre of Excellence in Natural Products and Therapeutics,Department of Biotechnology and Bioinformatics,Sambalpur University,Jyotivihar,Burla,Sambalpur,Odisha,India;Medical Research Laboratory,IMS and SUM Hospital,Siksha'O'Anusandhan Deemed to be University,K8,Kalinga Nagar,Bhubaneswar-751003,Odisha,India;School of Life Sciences,Sambalpur Univesity,JyotiviharBurla,Sambalpur,Odisha,India;ICMR-Regional Medical Research Centre,Chandrasekharpur,Bhubaneswar-751023,India;School of Pharmaceutical Sciences,Siksha'O'Anusandhan Deemed to be University,Bhubaneswar-751030,India
The structure of erastin-bound xCT-4F2hc complex reveals molecular mechanisms underlying erastin-induced ferroptosis
Renhong Yan;Enjun Xie;Yaning Li;Jin Li;Yuanyuan Zhang;Ximin Chi;Xueping Hu;Lei Xu;Tingjun Hou;Brent R.Stockwell;Junxia Mini;Qiang Zhou;Fudi Wang-Westlake Laboratory of Life Sciences and Biomedicine,Key Laboratory of Structural Biology of Zhejiang Province,Institute of Biology,Westlake Institute for Advanced Study,School of Life Sciences,Westlake University,Hangzhou,Zhejiang,China;Department of Biochemistry,School of Medicine,Southern University of Science and Technology,Shenzhen,Guangdong,China;The First Affiliated Hospital,The Fourth Affiliated Hospital,School of Public Health,Institute of Translational Medicine,Cancer Center,State Key Laboratory of Experimental Hematology,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China;The First Affiliated Hospital,The Second Affiliated Hospital,Basic Medical Sciences,School of Public Health,Hengyang Medical School,University of South China,Hengyang,Hunan,China;Beijing Advanced Innovation Center for Structural Biology,Tsinghua-Peking Joint Center for Life Sciences,School of Life Sciences,Tsinghua University,Beijing,China;Hangzhou Institute of Innovative Medicine,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou,Zhejiang,China;Institute of Bioinformatics and Medical Engineering,Jiangsu University of Technology,Changzhou,Jiangsu,China;Department of Biological Sciences and Department of Chemistry,Columbia University,New York,NY,USA
A novel PI3K inhibitor XH30 suppresses orthotopic glioblastoma and brain metastasis in mice models
Ming Ji;Dongjie Wang;Songwen Lin;Chunyang Wang;Ling Li;Zhihui Zhang;Jing Jin;Deyu Wu;Yi Dong;Heng Xu;Duo Lu;Xiaoguang Chen-State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。